Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorFujian Maternity and Child Health Hospital

About this trial

The clinical diagnosis and treatment data of 300 cases of cervical neuroendocrine tumors were collected, including age, preoperative biopsy pathology results, postoperative histopathological results, TCT results, and colposcopy biopsy pathology results. At the same time, paraffin tissue specimens (remaining specimens after pathological diagnosis) from 100 cases of cervical neuroendocrine tumors from multiple centers across the country were collected to establish a cervical neuroendocrine tumor data follow-up database. Protein concentration and omics analysis were performed on the data results, to evaluate the molecular characteristics and prognosis of cervical neuroendocrine tumor proteins, and to preliminarily explore its clinical application value.

Eligibility criteria

Qualifiers

Patients diagnosed with cervical neuroendocrine carcinoma by histopathology

Clinical data were complete

Disqualifiers

Patients who are not being treated in our hospital

Patients with lack of follow-up data, unable to obtain survival information

Patients call to refuse to participate in this project

The quality of paraffin specimens can not meet the requirements of proteome concentration determination

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed